All data are based on the daily closing price as of February 7, 2025
a

Apex Biotechnology Corp.

1733.TW
0.98 USD
0.01
+1.03%

Overview

Last close
0.98 usd
Market cap
97.59M usd
52 week high
1.38 usd
52 week low
0.81 usd
Target price
2.34 usd

Valuation

P/E
26.3889
Forward P/E
N/A
Price/Sales
1.866
Price/Book Value
1.7942
Enterprise Value
88.00M usd
EV/Revenue
1.5922
EV/EBITDA
15.0532

Key financials

Revenue TTM
52.30M usd
Gross Profit TTM
17.63M usd
EBITDA TTM
5.13M usd
Earnings per Share
0.03 usd
Dividend
N/A usd
Total assets
73.52M usd
Net debt
-7.84M usd

About

Apex Biotechnology Corp. researches, develops, manufactures, and sells home care medical devices by using biosensor technology worldwide. The company offers blood glucose, uric acid, hemoglobin, cholesterol, lactate, HbA1C, and ketone monitoring systems, as well as coagulation and multifunctional self-testing, and hemoglobin screening systems. It also provides pesticide residue check systems; and care management and tele-health services. The company was incorporated in 1997 and is headquartered in Hsinchu City, Taiwan.
  • Symbol
    1733.TW
  • Exchange
    TW
  • Isin
    TW0001733004
  • Country
    Taiwan
  • Sector
    Healthcare
  • Industry
    Biotechnology
  • CEO
  • Headquarter
    Hsinchu City
  • Web site
    https://www.apexbio.com
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top